Skip to content

Study on intracranial meningioma using PET ligand investigation during follow-up over years [SIMPLIFY]

Study on intracranial meningioma using PET ligand investigation during follow-up over years [SIMPLIFY] - MET PET meningeoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44234
Enrollment
35
Registered
2018-02-13
Start date
2018-10-05
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age above 18 years - Profound understanding of the Dutch language - Treatment with SRT for a intracranial meningioma with a pre-treatment MET-PET for radiation field planning purposes. - Able to give written informed consent

Exclusion criteria

Exclusion criteria: - Adverse reaction during previous MET-PET scan - Pregnancy

Design outcomes

Primary

MeasureTime frame
Difference (progression or not) between the MRI-only report and the MRI/MET-PET report

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)